FDA Inactive Ingredient Database

The FDA InACTive Ingredient Database is a public reference resource mAIntained by the U.S. Food and Drug Administration. It catalogs inactive ingredients, also called excipients, that APPear in FDA-approved drug products along with the routes of administration and maximum potency levels observed for each ingredient. Because it is published through the agency's public access data portal, it functions as a lookup tool rather than a Generative AI product, and it is wIDEly used by fORMulation scientists, regulatory specialists and phArmacy researchers who need a reliable starting point for excipient selection.

What it does

The database lets users search a large collection of inactive ingredients and see how each one has been used across approved drug products. Results are organized by ingredient and administration route, so a user can check whether a particular excipient has appeared in approved oral, topical, injectable or other dosage forms. This makes it eASIer to judge whether an ingredient is already established for a given route before comMITting to a formulation strategy.

Key capabilities

• Searchable index of inactive ingredients drawn from approved drug records.
• Route-of-administration breakdowns that show where each excipient has been used.
• Potency Information reflecting maximum levels reported for approved products.
• Multiple search modes, including lookup by ingredient name and by route.
• Downloadable data extracts for offline analysis and internal reference.
• Publicly accessible records with no account required for basic searching.

Who it is for

Pharmaceutical formulation scientists use the database to screen candidate excipients and to support early formulation decisions. Regulatory affairs Professionals consult it when preparing submissions or responding to questions about ingredient precedent. academic researchers and students in pharmaceutics rely on it for teaching and Literature Review. Quality and manufacturing teams may also reference it when comparing proposed ingredients against approved examples, though it should be treated as a reference point rather than a compliance determination.

How to get started

Open the database through the FDA's public access data site in a web browser. Enter an ingredient name or browse by administration route, then review the returned entries for route and potency context. Because the interface is utilitarian, it helps to have a clear question in mind, such as whether an excipient appears in injectable products. Data extracts can be downloaded for broader analysis, and results are best read alongside the underlying approved product labeling.

Pricing and access caveat

The database is offered at no cost as a public government resource, and no subscription is required. Availability, update cadence and interface details may change without notice, and the records reflect information as submitted for approved products rather than real-time scientific consensus. Users should verify findings against current labeling and applicable regulations before relying on them for development or submission decisions.